Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2021-01-29

Clinical Trial Update: A Single-center, Retrospective Study to Evaluate the Clinical Performance of Artificial Intelligence Medical Assisted Diagnostic Software (VeriSee DR) for Screening of Diabetic Retinopathy in Patients With Diabetes Mellitus

View source ↗

Summary

A retrospective single-center study evaluated the clinical performance of VeriSee DR AI software for screening diabetic retinopathy in diabetes patients; study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VeriSee DR

Snippet

Sponsor: Acer Being Health Inc. | Conditions: Diabetic Retinopathy | Status: COMPLETED | Results posted: 2021-01-29